LY96 and atrial fibrillation: TLR4, in association with MD-2, detects lipopolysaccharides (LPSs) from Gram-negative bacteria like Klebsiella and Escherichia, which are implicated in conditions such as human atrial fibrillation (AF) [5,6,7,8].